Key result
Recent research highlights the evolving clinical roles of PCI, novel antiplatelet therapies, and TAVI.
Why the study?
The role of PCI in stable coronary disease has been reappraised following evidence that optimal medical therapy may provide similar cardiovascular outcomes without incremental benefits from PCI.
Does percutaneous coronary intervention improve cardiovascular outcomes compared to optimal medical therapy in patients with stable coronary disease?
Does percutaneous coronary intervention improve cardiovascular outcomes compared to optimal medical therapy in patients with stable coronary disease?
In stable coronary disease, PCI does not improve hard cardiovascular outcomes compared to optimal medical therapy, reinforcing contemporary guideline advice.
Authors
No takes yet. Share an insight, caveat, or question.
Supports preference for optimal medical therapy in stable CAD; level 5 review leaves open net effects of evolving interventions.
Meier et al. (2013) conducted a review in Cardiovascular disease. Cardiovascular interventions and therapies was evaluated. Recent research in clinical cardiology highlights the evolving roles of percutaneous coronary intervention, novel antiplatelet therapies, and transcatheter aortic valve implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: